Invivyd to Participate at the Jefferies Healthcare Conference
June 01 2023 - 7:00AM
Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical
company on a mission to protect the vulnerable from serious viral
infectious diseases, today announced that David Hering, chief
executive officer of Invivyd, is scheduled to present at the
Jefferies Healthcare Conference on Friday, June 9, 2023 at 11:30
a.m. ET in New York, NY.
In addition to the presentation, the management
team will host investor meetings at the conference. Investors
participating in the conference who are interested in meeting with
Invivyd management should contact their Jefferies
representative.
A live webcast of the presentation will be
available in the investor section of the company's website at
investors.invivyd.com and will be archived for approximately 90
days following the presentation.
About InvivydInvivyd, Inc.
(Nasdaq: IVVD) is a biopharmaceutical company on a mission to
rapidly and perpetually deliver antibody-based therapies that
protect vulnerable people from the devastating consequences of
circulating viral threats, beginning with SARS-CoV-2. Invivyd’s
technology works at the intersection of evolutionary virology,
predictive modeling, and antibody engineering, and is designed to
identify high-quality, long-lasting antibodies with the potential
to resist viral escape. The company is generating a robust pipeline
of product candidates which could be used in prevention or
treatment of serious viral diseases, starting with COVID-19 and
expanding into influenza and other high-need indications.
Visit https://invivyd.com/ to learn more.
Media Contact:Kate Burdick, Evoke
Canale860-462-1569kate.burdick@evokegroup.com
Investor Contact:Chris Brinzey,
ICR Westwicke339-970-2843chris.brinzey@westwicke.com
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From Apr 2024 to May 2024
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From May 2023 to May 2024